心泰医疗:封堵器类产品预计销售增长目标约为30%及经导管主动脉瓣置换术产品预计销售目标约2亿元 4月23日复牌

智通财经
22 Apr

智通财经APP讯,心泰医疗(02291)公布,董事会留意到近期公司股份在联交所的价格及成交量的波动以及公司控股股东之一,乐普(北京)医疗器械股份有限公司(其股份于深圳证券交易所创业板上市,证券代码:300003),于2025年4月21日发布的投资者关系活动记录表,当中分别提及该公司的封堵器类产品预计销售增长目标约为30%及经导管主动脉瓣置换术产品预计销售目标约为人民币2亿元,其实现存在不确定性并...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10